Y. Cao, . F. . Shi, Y. . Li, X. . Wei, . H. . Yi, and S. . Han, “Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China”, Health Decision, vol. 2, no. S1, Jul. 2024.